SABINA INTERNATIONAL

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT03857178

D589SR00002

Details and patient eligibility

About

The aim of the study is to describe the prescribing pattern of the different types of medications which are used to treat asthma, across multiple countries.

Enrollment: 8,617 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Male and female patients ≥12 years-old
2. Documented diagnosis with Asthma as per medical records.
3. Have had ≥3 consultations with the HCP at study start date
4. After full explanation, a patient or legal guardian must have signed an informed consent document indicating that they understand the purpose of and the procedures required for the study and are willing to participate in the study.

Exclusion criteria

1. Patient with a diagnosis of chronic obstructive pulmonary disease or other chronic respiratory disease different from Asthma.
2. An acute or chronic condition that, in the investigator's opinion, would limit the patient's ability to participate in this study